Medical Journals

Activation of the Erk8 Mitogen-activated Protein (Map) Kinase by Ret/Ptc3, a Constitutively Active Form of the Ret Proto-oncogene.

Authors:
  • Iavarone Carlo
  • Acunzo Mario
  • Carlomagno Francesca
  • Catania Annunziata
  • Melillo Rosa M
  • Carlomagno Stella M
  • Santoro Massimo
  • Chiariello Mario

From: Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università degli Studi di Napoli Federico II, Via Pansini 5, 80131 Naples, Italy.

The Journal of biological chemistry

  • Publish Date: Apr 2006
  • ISSN: 0021-9258
  • Volume: 281
  • Issue: 15
  • Pages: 10567-76
  • Medium: Print
  • Language: English
  • Citation (JAMA): Iavarone Carlo, Acunzo Mario, Carlomagno Francesca, et al. Activation of the Erk8 Mitogen-activated Protein (Map) Kinase by Ret/Ptc3, a Constitutively Active Form of the Ret Proto-oncogene.. J. Biol. Chem. Apr 2006;281:10567-76

Abstract

Mitogen-activated protein (MAP) kinases have a central role in several biological functions, including cell adhesion and spreading, chemotaxis, cell cycle progression, differentiation, and apoptosis. Extracellular signal-regulated kinase 8 (Erk8) is a large MAP kinase whose activity is controlled by serum and the c-Src non-receptor tyrosine kinase. Here, we show that RET/PTC3, an activated form of the RET proto-oncogene, was able to activate Erk8, and we demonstrate that such MAP kinase participated in RET/PTC3-dependent stimulation of the c-jun promoter. By using RET/PTC3 molecules mutated in specific tyrosine autophosphorylation sites, we characterized Tyr(981), a known binding site for c-Src, as a major determinant of RET/PTC3-induced Erk8 activation, although, surprisingly, the underlying mechanism did not strictly depend on the activity of Src. In contrast, we present evidence that RET/PTC3 acts on Erk8 through Tyr(981)-mediated activation of c-Abl. Furthermore, we localized the region responsible for the modulation of Erk8 activity by the RET/PTC3 and Abl oncogenes in the Erk8 C-terminal domain. Altogether, these results support a role for Erk8 as a novel effector of RET/PTC3 and, therefore, RET biological functions.

Mesh Headings (Keywords): Amino Acid Sequence, Animals, Base Sequence, Binding Sites, Blotting, Western, Cell Line, Cell Line, Tumor, Enzyme Activation, Extracellular Signal-Regulated MAP Kinases, Genes, Reporter, Genetic Vectors, Humans, MAP Kinase Signaling System, Mice, Molecular Sequence Data, Mutation, Phosphorylation, Promoter Regions (Genetics), Protein Binding, Protein Structure, Tertiary, Proto-Oncogene Proteins c-jun, Proto-Oncogene Proteins c-ret, Signal Transduction, Thyroid Neoplasms, Transfection, Tyrosine, src-Family Kinases


Check for Full Text / PubMed Unique Identifier (PMID): 16484222


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.